asxan.ai Agents Hub

SCIENCE · EVIDENCE · REGULATION

Decode the science
Prove the evidence
Clear the regulation

Every ingredient, traceable from cell to citation to clearance — PMID evidence and FDA · EFSA · ANVISA context.

Browse ingredients Explore by goal Explore by lifestyle Contact
TrustScore · Tier A · strong

Astaxanthin (Haematococcus pluvialis)

Natural carotenoid from Haematococcus pluvialis, mapped across four mechanism axes — singlet-oxygen quenching, NRF2 activation, NF-kB modulation. Tier-A evidence: 10 meta-analyses and 33 human RCTs across 51 PubMed-indexed papers.

  • 10 Meta/SR
  • 33 RCT
  • 51 PMID

Regulatory context

  • FDA · US Compliant GRAS / NDI — no authorized health claim
  • EFSA · EU Compliant Novel Food market access — no authorized claim
  • ANVISA · BR Compliant IN 28/2018 constituent (≤6 mg/d) — no functional claim

About ASXAN Group

VITAL CODE, LIFE POWER

asxan.ai is the evidence library of ASXAN BIOTECH GROUP — a multi-national biotech group whose mission is to "Boost Each Cell with Biotech." The group spans synthetic biology, clinical application, brand development, and a microalgae cell factory at altitude.

Global presence

Manufacturing across 5 countries · operations across 100+

100+
Countries served

Operations across more than 100 countries.

6
Business-center regions

North America · South America · East Asia · Southeast Asia · Europe · Oceania.

5
Manufacturing countries

China · USA · Brazil · New Zealand · Thailand.

8+
Regional branches

China · North America · South America · Europe · Australia & New Zealand · Japan · South Korea · Southeast Asia.

Technology

Three R&D platforms · three core technologies

R&D platforms

  • SynBio Lab Programs nature beyond extraction · cell factories · pathway engineering.
  • Clinical Application Lab Translates molecular targets into evidence-anchored ingredient claims.
  • Neural Media Studio Brand development and the International Nutrient Brand Matrix.

Core technologies

  • Closed Photocell Culture Pollution-free, high-purity cell cultivation under controlled photobioreactor conditions.
  • Supercritical Fluid Extraction Solvent-residue-free recovery of fat-soluble compounds (carotenoids, omega-3, lipid actives).
  • Nanoscale Microcapsule Packaging Multi-layer formulation that improves stability, controls release, and supports bioavailability.

Flagship facility

Microalgae Cell Factory · Yunnan, 1,880 m altitude

Closed-system photobioreactor cultivation supporting downstream carotenoid, omega-3, and biomass production at industrial scale.

200,000m²
Photobioreactor coverage
2,500+km
Photobioreactor pipeline
200,000+kg / yr
Microalgae biomass capacity
6,000+t CO₂ / yr
Annual carbon sequestration

Industries served

  • Agriculture
  • Food
  • Nutraceuticals
  • Pharma
  • Skincare
  • Healthcare

Evidence atlas

Four routes into the same source-linked corpus: ingredients for formulation, articles for reasoning, goals for positioning, and lifestyle pages for product context.

Dossier
Ingredients

Browse PubMed-anchored ingredient monographs by body system, mechanism, and evidence tier.

 Analysis
Evidence Articles

Read long-form decision trees, RCT histories, and head-to-head ingredient comparisons.

 Decision
Health Goals

Translate evidence into goal-oriented ingredient stacks with clear boundaries.

 Context
Lifestyle Guides

Map ingredient choices to life-stage, diet, and product-development scenarios.

Featured dossiers

Start where product decisions usually begin.

These entry points connect evidence depth with the categories nutrition technology teams already plan around: carotenoids, omega-3, NAD+, protein quality, vitamins, and microbiome support.

Read evidence articles
Astaxanthin carotenoid · 4-axis mechanism Omega-3 hub EPA/DHA/ALA · 4 sub-source cluster NAD+ cluster NMN/NR/NMNH/NADH 5 form Protein hub 6 sub-source DIAAS framework Vitamin D3 VITAL trial cluster Creatine sports & cognition Natural vs Synthetic Astaxanthin 28 PMID Omega-3 25-year CV + EPA Inflammation 28 PMID Protein Decision Tree (Whey vs Yeast) 25 PMID

Agent ledger

Machine-readable, human-auditable.

The schema, breadcrumb, cluster-topology, and PMID-coverage metrics are produced by ASXAN build-time audit. They support monitoring and AI-agent discovery, while independent validation remains available through public structured-data validators.

Ask Agent Axor